Aflibercept is a recombinant fusion protein derived from the fusion of the extracellular binding domain of human vascular endothelial growth factor (VEGF) receptor 1 and receptor 2 with the Fc segment of human immunoglobulin G1. It is a highly effective anti-VEGF drug and has the effect of inhibiting neovascularization. Aflibercept is mainly used to treat a variety of conditions such as eye diseases, tumors and cardiovascular diseases.
Product Name: Aflibercept
Concentration: 40mg/ml
CAS:845771-78-0
Quantity:10mg, 50mg, 100mg.
苏州锦骊生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
张经理